-- Vital information on FDA's new Risk Communications Advisory Committee;
-- An inside look at FDA's overall risk communications strategy from its Director of Risk Communication, Nancy Ostrove; and
-- Excerpts from FDA's Response to the IOM's Report on Drug Safety.
The expert panel includes:
-- Nancy Ostrove, Director, Risk Communication, FDA;
-- Randall Lutter, Deputy Commissioner for Policy & Planning, FDA;
-- Stuart Pape, Managing Partner, Patton Boggs;
-- Robert Dormer, Partner, Hyman Phelps & McNamara;
-- Grace-Marie Turner, President, Galen Institute;
-- Susan Newberry, Senior Vice President, Director, D.C Healthcare Practice, Ketchum Communications; and
-- Kelly Posner, Associate Professor, Columbia University.
Registration is $295 for FDLI members, $395 for non-members. Attendance is limited, so registrants are strongly urged to sign up early.
To register, visit http://fdli.org or call +1-800-956-6923 or +1-202-371-1420.
Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.
|SOURCE Food & Drug Law Institute|
Copyright©2007 PR Newswire.
All rights reserved